Literature DB >> 26292193

The Frequency of Postreduction Interventions After Successful Enema Reduction of Intussusception.

Elisabeth M Lessenich1, Amir A Kimia2, Katherine Mandeville2, Joyce Li2, Assaf Landschaft2, Andy Tsai3, Richard G Bachur2.   

Abstract

OBJECTIVES: The objective was to determine the frequency of postreduction, hospital-level interventions among children with successful reduction of ileocolic intussusception and identify factors that predict the need for such interventions.
METHODS: This was a retrospective cross-sectional study of children who underwent successful enema reduction for ileocolic intussusception at a single emergency department. Hospital-level interventions were included if they occurred within 24 hours of reduction and were further classified as either major (recurrence or possible perforation) or minor (imaging for suspected recurrence or administration of parenteral narcotics or antiemetics). Binary logistic regression was used to identify predictors for hospital-level interventions.
RESULTS: A total of 464 children underwent enema reduction. The median age was 1.7 years (interquartile range [IQR] = 0.8 to 2.5 years), and 66% were male. A total of 435 (94%) were hospitalized with a median hospital stay of 25 hours (IQR = 19 to 34 hours). Nineteen percent (95% confidence interval [CI] = 15% to 22%) needed postreduction interventions, including 6% (95% CI = 4% to 9%) who required major interventions. The median time to any hospital intervention was 9.9 hours (IQR = 6.3 to 16.4 hours). We identified two independent predictors for hospital-level interventions: duration of symptoms > 24 hours (adjusted odds ratio [OR] = 2.1, 95% CI = 1.3 to 3.4) and location of the intussusception tip at (or proximal to) the hepatic flexure (adjusted OR = 1.9, 95% CI = 1.1 to 3.3); the latter factor was also a predictor of a major intervention. None of the children (95% CI = 0 to 1.0%) had an acute decompensation after an initially successful enema reduction.
CONCLUSIONS: Clinical decompensation is rare and recurrence is relatively low after an uncomplicated reduction of ileocolic intussusception. However, one in five children required hospital-level interventions after reduction. Children with the intussusception tip at (or proximal to) the hepatic flexure, and those with symptoms for longer than 24 hours, are more likely to require subsequent interventions. Although outpatient management appears safe after a period of observation, caregivers should be counseled about the risk of ongoing symptoms and recurrence.
© 2015 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2015        PMID: 26292193     DOI: 10.1111/acem.12741

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  4 in total

1.  Air contrast enema reduction of single and recurrent ileocolic intussusceptions in children: patterns, management and outcomes.

Authors:  Grace Mang Yuet Ma; Craig Lillehei; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2020-01-31

2.  Impact of a Standardized Clinical Pathway for Suspected and Confirmed Ileocolic Intussusception.

Authors:  Corinne E Shubin; Lori E Rutman; A Luana Stanescu; Surabhi B Vora; George T Drugas; Michael G Leu; Rebekah A Burns
Journal:  Pediatr Qual Saf       Date:  2020-05-28

Review 3.  Management of intussusception in children: A systematic review.

Authors:  Lorraine I Kelley-Quon; L Grier Arthur; Regan F Williams; Adam B Goldin; Shawn D St Peter; Alana L Beres; Yue-Yung Hu; Elizabeth J Renaud; Robert Ricca; Mark B Slidell; Amy Taylor; Caitlin A Smith; Doug Miniati; Juan E Sola; Patricia Valusek; Loren Berman; Mehul V Raval; Ankush Gosain; Matthew B Dellinger; Stig Sømme; Cynthia D Downard; Jarod P McAteer; Akemi Kawaguchi
Journal:  J Pediatr Surg       Date:  2020-10-06       Impact factor: 2.545

4.  Effectiveness of the implementation of pediatric intussusception clinical pathway: A pre- and postintervention trial.

Authors:  So Hyun Paek; Do Kyun Kim; Young Ho Kwak; Jae Yun Jung; Seuk Lee; Joong Wan Park
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.